Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$NLST JUST IN CASE YOU MISSED IT
Judge Seeborg has ruled on Claim 16 and denied intervening rights to Google, a massive win for Netlist. This makes Google liable for infringement of Netlist technology dating all the way back to February 2004. Billions of extra dollars of value were added to the lawsuit because of this ruling.
I give a Strong Buy rating to Netlist (OTCQB:NLST) because I believe they are in the largest patent infringement lawsuit in history. In addition to being in a massive lawsuit, they are a rapidly growing tech company that has grown revenues over 200% Y/Y. Since I have been covering Netlist, I have dubbed it to be in "the lawsuit of the century." Additionally, I also use "potentially largest patent infringement lawsuit in history." These phrases became one step closer to reality when Netlist won a critical court decision versus Google (GOOG) (GOOGL) on May 5th, 2022.
Taken from Seeking Alpha
345,861,430 Selling
74,576,874 Buying
If this is any sign of what's going to happen it can't be good.
STAY TUNED
I hope NetList is getting ready for the Nasdaq.
$$$ NLST $$$
$$$ NLST $$$
$$$ NLST $$$
Some people like that, I'm holding
My guess M or A before the May 23 2023 dead line.
GLTA
Tan posted Nov. 16, 22
With our 10-Q filed and $10M financing agreement in place,
@Vemanti $VMNT is now focusing on M&A transactions.
Enjoy the rest of your week!
Tan posted April 18, 23
After thousands of hours, we've reached a major milestone for
@Vemanti $VMNT. Official announcement coming soon!
#digitalbanking #CloudComputing #ArtificialIntelligence #MachineLearning #Web3 #Blockchain #SoutheastAsia
April 16, 2023
https://newsytrends.com/2023/04/16/vemanti-group-inc-otcmkts-vmnt-on-the-move-northbound-as-fintech-looks-to-uplist-shares-partners-with-finastra-to-build-southeast-asias-first-sme-focused-neobank/
Agree, but they're going to need
Merck, Pfizer or one the big pharmaceuticals too
help them. What they have 46 patents?
This thing could take off with the right partner & news.
$$$ PPCB $$$
$PPCB
Read this paragraph very carefully and you will see the Great position PPCB is in to getting the Orphan Drug Designation conferred for PRB.
PRP is an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention. PRP is a combination of the pancreatic proenzymes, trypsinogen and chymotrypsinogen. PRP produces multiple effects on cancerous cells intended to inhibit tumor growth and potentially stop a tumor from spreading through the body.
We received notification from the U.S. Food and Drug Administration (βFDAβ) that PRP had been conferred Orphan Drug Designation for the treatment of pancreatic cancer. This special status is granted when a rare disease or condition is implicated and a potential treatment qualifies under the Orphan Drug Act and applicable FDA regulations.
A Certificate for Advance Overseas Finding was received from the Board of Innovation and Science Australia to receive up to a 43.5% βcash backβ benefit from overseas R&D expenses. The finding relates to the planned Phase 1 clinical trial β Multiple Ascending Dose Studies of proteolytic proenzymes for the treatment of advanced cancer patients suffering from solid tumors planned to be conducted at the Peter MacCallum Center, Melbourne, Australia. Overseas activities to be undertaken include the development of an analytical assay for the quantification of active pharmaceutical ingredients in the Companyβs lead product candidate, PRP, and its manufacture of the finished product for the Phase 1 clinical trial.
$PPCB Let's go.
Anyone what's the Float on NVOS? Thanks.
Netlist The case against Samsung is getting closer, and
victory will be huge with repercussions also for the Google case.
$$$ STAY TUNED $$$
These guys made a mistake by not going with the Nova Graphene Ballistics.
The Name Change as well as the business.
Making the fitted Vest for
USA Military and Police Force common sense.
$VMNT will the chase continue all the way to the Nasdaq?
Yes, for those who have $$$ Paytience $$$.
$PPCB Time Bomb Ticking
Stay Tuned
HIGH TECHNICAL ATTRIBUTE $$$ VMNT $$$
has a High Technical Rating by Nasdaq Dorsey Wright.
Discover why technical analysis matters.
OK VEMANTI GROUP MAKE IT HAPPEN
$VMNT trying to visualize
@Vemanti Group
running a successful business. Some great
thinks where said. No R/S in 2023, VMNT
owns 100% of the platform. Pilot lunch Jun/Jul.
Enough funding lined up for the NASDQ, by EOY.
PICK UP SOME PIECES N LET'S ENJOY THE RIDE.
DROP THE LINK.
Anyone is William Hartman still President and CEO ?
My thing is this the product will come out.
Who will produce it?
BIEI
or
Nova
With all the excitement around the stock new eyes with
big money could have made Nova a better offer.
Remember their FB page made it official, for right now. That they're out. "No Deal"
Now comes the good part. Why can't BIEI make their own Graphene Ballistics Gear?
Born in the USA Born to Protect.
Is Optilan part of the merger?
I think things will work out. My question is how many
shares of the new company will you receive if you
own 5 million shares? According to this
As part of the transaction, all DarkPulse shares owned by DarkPulseβs existing equity holders will be converted to common stock of the pro forma company.
FDA Approval would bring an end to penny land.
A/S 40,000,000,000 .
R/S 1 for 10
or
1 for 20
Buy, Hold, lock up the Float.
Force a Squeeze
$IQST
$IQST Did you think the holders of a 100 million dollar short position were just going to roll over? Not likely. We have to shoot them in the face until they die. Round 2 incoming. That's where the fun starts.
Whale Team It's time to rock
I'm totally correct you'll see once it's completed.
If they use 100 as the ratio. I've heard 100 or 150
Take your current shares and divide them by 100.
Now multiply it by that .05 cent or .07 cent number they say it'll be.
10,000,000 shares/100 = 100.000 shares
100,000 shares X .05 = $5000
100 - 150 is the ratio
Therefore
10,000,000,000 / 100 = 100,000,000 < This would be the new A/S
Use 150 instead of 100 to get the other value
Then you'll have to divide your shares buy 100.
If you had 10,000,000 million shares divide by 100 =
100,000 shares x .05 = $5000
He said 5 cent maybe more.
A/S 10,000,000,000
We don't know the Ratio. I'll use 1000
10.000.000.000 / 1000 = 10,000,000
The new A/S would be 10,000,000
Let's say I currently have 10,000,000 shares.
Not knowing the ratio I'll use the same 1000
My 10,000,000sh / 1000 = 10,000sh
10,000 X .05 = $500
Need to know the Ratio
Ratio above 1000 for 1
Meaning:
For every 1000 shares you have you'll receive 1 share
If they use 10,000,000,000 / 500
It would leave them with A/S of 20,000,000
My 10 million would = 20,000 X .05 = $1000
10,000,000,000 / 200 would make the A/S 50,000,000
My 10,000,000 / 200 = 50,000 X .05 = $2500
10,000,000,000 / 2 new A/S 5,000,000,000
My 10,000,000 / 2 = 5,000,000 X .05 = $250,000
I'll add after the R/S but not before the drop do to the R/S.
Agree and that's what I posted
" I did listen to the whole video
all of it. They even talk about
the company not having any
debt."
I did listen to the whole video
all of it. They even talk about
the company not having any
debt.
1/6 Goals for 2022. pic.twitter.com/cV6eO8s7OP
— UNJA πΉπΌππ°π―π΅ (@Unidentified_NJ) March 28, 2022